miR-107 exerts its tumor-suppressive effects by directly targeting hypoxia-inducible factor-1β (HIF-1β), a key regulator of tumor cell metabolism, angiogenesis, and survival under hypoxic conditions [142]. This evidence concerns the gene ARNT and neoplasm.